Haemoglobinopathy Flashcards
structure of haemoglobin
tetramer made of 2 alpha and 2 beta chains
how many haem groups are attached to each globin chain
one
use of globin chains on heme
keep it soluble and protect it from oxidation
in adults which form of haemoglobin is major present form
HbA
major forms of haemoglobin
HbA 2 alpha chains and 2 beta chains α2β2
HbA2 2 alpha and 2 delta chains α2δ2
HbF 2 alpha and 2 gamma chains
what are haemoglobinopathies
term for any hereditary conditins affecting global chain synthesis
autosomal recessive
two groups of haemoglobinopathies
Thalassaemias; decreased rate of globin chain synthesis
Structural haemoglobin variants; mutations in globin genes leading to altered structures of haemoglobin molecule
consequences of thalassemias
Inadequate Hb production → microcytic hypochromic anaemia
If severe:
Unbalanced accumulation of globin chains which are toxic to the cell
Ineffective erythropoiesis
Haemolysis
alpha thalassaemia
mutations affecting alpha globin chain synthesis
results from deletion
normal people have four alpha genes
alpha thalassaemia trait
one or two alpha genes missing
asymptomatic carrier state, microcytic hypochromic red cells but ferritin normal
HbH disease
only one alpha gene left
moderate to severe anemia
very low MCV and MCH
jaundice, splenomegaly
common in se asia
hb barts hydrops fetalis
no functional alpha genes
incompatible with life
Profound anaemia
Cardiac failure
Growth retardation
Severe hepatosplenomegaly
Skeletal and cardiovascular abnormalities
Almost all die in utero
beta thalassaemia and common cause
disorder of beta chain synthesis and caused by point mutations
b thalassaemia major
Presents aged 6-24 months (as HbF falls)
Pallor, failure to thrive
Extramedullary haematopoiesis causing;
Hepatosplenomegaly
Skeletal changes
Organ damage
lifelong transfusion dependancy
consequences of iron overload
Endocrine dysfunction
Impaired growth and pubertal development
Diabetes
Osteoporosis
Cardiac disease
Cardiomyopathy
Arrhythmias
Liver disease
Cirrhosis
Hepatocellular cancer